Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript | Seeking Alpha
Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsChristopher Ward - Senior Director of Investor RelationsStuart Essig - CEO, President &. . .
Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsChristopher Ward - Senior Director of Investor RelationsStuart Essig - CEO, President & ChairmanLea Knight - Executive VP & CFOConference Call ParticipantsIseult McMahon - BTIG, LLC, Research DivisionRavi Misra - Truist Securities, Inc. , Research DivisionRoss Osborn - Wells Fargo Securities, LLC, Research DivisionRei Tan - BofA Securities, Research DivisionK. Gong - JPMorgan Chase & Co, Research DivisionElaine Cui - Raymond James & Associates, Inc. , Research DivisionPresentationOperatorGood day and thank you for standing by. Welcome to the Integra LifeSciences Second Quarter 2026 Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Chris Ward, Senior Director of Investor Relations. Christopher WardSenior Director of Investor RelationsGood morning, and thank you for joining the Integra LifeSciences Second Quarter 2026 Earnings Conference Call. Joining me on the call are Stuart Essig, Chairman, President, and Chief Executive Officer, and Lea Knight, Chief Financial Officer. We issued a press release this morning announcing our second quarter 2026 financial results. Release and earnings presentation we referenced during the call are available on integralife. com under Investors, Events and Presentations. Look for the file named Second Quarter 2026 Earnings Call Presentation. Before we begin, I want to remind you that many statements made during this call may be considered forward-looking. Factors that cause actual results to differ materially are discussed in the company's Exchange Act reports filed with the SEC. These factors are also detailed in the release. Also in our prepared remarks, we will reference reported and organic revenue growth. Organic revenue growth excludes the effects of foreign currency, acquisitions, and divestitures. Unless otherwise stated, all disaggregated and franchise-level revenue growth